Gentamicin and Hypoxic-ischaemic encephalopathy - a phase IV clinical study of FDA data

Summary:

Hypoxic-ischaemic encephalopathy is reported as a side effect among people who take Gentamicin (gentamicin sulfate), especially for people who are male, 2-9 old, also take Phenytoin, and have Status epilepticus.

The phase IV clinical study analyzes which people have Hypoxic-ischaemic encephalopathy when taking Gentamicin. It is created by eHealthMe based on reports of 21,523 people who have side effects when taking Gentamicin from the FDA, and is updated regularly.

What is Gentamicin?

Gentamicin has active ingredients of gentamicin sulfate. It is often used in urinary tract infection. eHealthMe is studying from 21,654 Gentamicin users. Check the latest studies of Gentamicin.

What is Hypoxic-ischaemic encephalopathy?

Hypoxic-ischaemic encephalopathy (a condition that occurs when the entire brain is deprived of an adequate oxygen supply, but the deprivation isn't total) is found to be associated with 372 drugs and 599 conditions by eHealthMe. Check the latest studies of Hypoxic-ischaemic encephalopathy.



On Jul, 14, 2026

21,523 people reported to have side effects when taking Gentamicin.
Among them, 19 people (0.09%) have Hypoxic-ischaemic encephalopathy.

Could Gentamicin cause Hypoxic-ischaemic encephalopathy?

Among these 19 people:

What is the gender of people who have Hypoxic-ischaemic encephalopathy when taking Gentamicin? *

  • female: 5.56 %
  • male: 94.44 %

What is the age of people who have Hypoxic-ischaemic encephalopathy when taking Gentamicin? *

  • 0-1: 33.33 %
  • 2-9: 61.11 %
  • 10-19: 5.56 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

What are other drugs people take besides Gentamicin? *

  1. Phenytoin: 15 people, 78.95%
  2. Lamotrigine: 11 people, 57.89%
  3. Valproate Sodium: 10 people, 52.63%
  4. Clobazam: 10 people, 52.63%
  5. Erythromycin: 10 people, 52.63%
  6. Cefotaxime: 7 people, 36.84%
  7. Piperacillin: 6 people, 31.58%
  8. Clonazepam: 5 people, 26.32%
  9. Diazepam: 5 people, 26.32%
  10. Furosemide: 4 people, 21.05%

What are other side effects people have besides Hypoxic-ischaemic encephalopathy? *

  1. Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 11 people, 57.89%
  2. Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 11 people, 57.89%
  3. Mycoplasma Infection (bacterial infection): 8 people, 42.11%
  4. Cerebral Atrophy (decrement in size of brain): 7 people, 36.84%
  5. Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 7 people, 36.84%
  6. Speech Impairment (Adult) (inability to speak (adult)): 7 people, 36.84%
  7. Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 7 people, 36.84%
  8. Hypotonia (low muscle tone): 7 people, 36.84%
  9. Learning Disorder (the brain's disability to receive, process, store, respond to and communicate information): 6 people, 31.58%
  10. Cardiac Failure Congestive: 6 people, 31.58%

What are the existing conditions these people have? *

  1. Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 11 people, 57.89%
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 10 people, 52.63%
  3. Pneumonia Mycoplasmal (mycoplasma pneumonia (mp) is a contagious respiratory infection): 9 people, 47.37%
  4. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 5 people, 26.32%
  5. Cardiac Failure: 3 people, 15.79%
  6. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 10.53%
  7. Sepsis (a severe blood infection that can lead to organ failure and death): 1 person, 5.26%
  8. Pneumonia: 1 person, 5.26%
  9. Birth Control: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Gentamicin and have Hypoxic-ischaemic encephalopathy?

- Check whether Hypoxic-ischaemic encephalopathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gentamicin:

Hypoxic-ischaemic encephalopathy treatments and more:

How severe was Hypoxic-ischaemic encephalopathy and when was it recovered:

Expand to all the drugs that have ingredients of gentamicin sulfate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gentamicin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypoxic-ischaemic encephalopathy:

Browse all the conditions that are associated with Hypoxic-ischaemic encephalopathy:


How the study uses the data?

The study uses data from the FDA. It is based on gentamicin sulfate (the active ingredients of Gentamicin) and Gentamicin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: